Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

Caleb M. Adler, Anil K. Malhotra, Igor Elman, Terry Goldberg, Michael Egan, David Pickar, Alan Breier

Research output: Contribution to journalArticle

256 Citations (Scopus)

Abstract

Objective: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. Method: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N=10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N=15) who did not receive ketamine. Results: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. Conclusions: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.

Original languageEnglish (US)
Pages (from-to)1646-1649
Number of pages4
JournalAmerican Journal of Psychiatry
Volume156
Issue number10
DOIs
StatePublished - Oct 1999

Fingerprint

Ketamine
Schizophrenia
Healthy Volunteers
N-Methylaspartate
Language
Communication
Inpatients
aspartic acid receptor

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. / Adler, Caleb M.; Malhotra, Anil K.; Elman, Igor; Goldberg, Terry; Egan, Michael; Pickar, David; Breier, Alan.

In: American Journal of Psychiatry, Vol. 156, No. 10, 10.1999, p. 1646-1649.

Research output: Contribution to journalArticle

Adler, Caleb M. ; Malhotra, Anil K. ; Elman, Igor ; Goldberg, Terry ; Egan, Michael ; Pickar, David ; Breier, Alan. / Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. In: American Journal of Psychiatry. 1999 ; Vol. 156, No. 10. pp. 1646-1649.
@article{b4050a7d74124e72be2e86041c4811b2,
title = "Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia",
abstract = "Objective: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. Method: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N=10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N=15) who did not receive ketamine. Results: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. Conclusions: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.",
author = "Adler, {Caleb M.} and Malhotra, {Anil K.} and Igor Elman and Terry Goldberg and Michael Egan and David Pickar and Alan Breier",
year = "1999",
month = "10",
doi = "10.1176/ajp.156.10.1646",
language = "English (US)",
volume = "156",
pages = "1646--1649",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "10",

}

TY - JOUR

T1 - Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

AU - Adler, Caleb M.

AU - Malhotra, Anil K.

AU - Elman, Igor

AU - Goldberg, Terry

AU - Egan, Michael

AU - Pickar, David

AU - Breier, Alan

PY - 1999/10

Y1 - 1999/10

N2 - Objective: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. Method: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N=10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N=15) who did not receive ketamine. Results: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. Conclusions: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.

AB - Objective: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. Method: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N=10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N=15) who did not receive ketamine. Results: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. Conclusions: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0032859516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032859516&partnerID=8YFLogxK

U2 - 10.1176/ajp.156.10.1646

DO - 10.1176/ajp.156.10.1646

M3 - Article

C2 - 10518181

AN - SCOPUS:0032859516

VL - 156

SP - 1646

EP - 1649

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 10

ER -